Mixed Results With Afinitor in Advanced Breast Cancer (CME/CE)

(MedPage Today) -- Results in women with HER2-positive disease fall short, but a subset of patients see some survival benefit.
Source: MedPage Today Meeting Coverage - Category: Journals (General) Source Type: news